The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: Phase 2 basket study.
 
Ozgur Karakuzu
No Relationships to Disclose
 
Apostolia Maria Tsimberidou
Consulting or Advisory Role - Tempus
Research Funding - Agenus (Inst); Boston Biomedical (Inst); IMMATICS (Inst); Karus Therapeutics (Inst); OBI Pharma (Inst); Parker Institute for Cancer Immunotherapy (Inst); Placon (Inst); Stem Cells, Inc. (Inst); Tempus (Inst)
Travel, Accommodations, Expenses - Japanese Society of Clinical Oncology
 
Veronica R. Holley
No Relationships to Disclose
 
Abha Adat
No Relationships to Disclose
 
Sapna Pradyuman Patel
Honoraria - Merck
Consulting or Advisory Role - Cardinal Health; TriSalus Life Sciences
Research Funding - Bristol-Myers Squibb (Inst); Deciphera (Inst); Foghorn Therapeutics (Inst); InxMed (Inst); Novartis (Inst); Provectus (Inst); Reata Pharmaceuticals (Inst); TriSalus Life Sciences (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Clinica Santa Maria; Merck
Other Relationship - Immunocore
 
Anil K. Sood
Employment - Amgen (I)
Stock and Other Ownership Interests - Bio-Path Holdings, Inc
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - KIYATEC; Merck; Merck
Research Funding - MTrap
Patents, Royalties, Other Intellectual Property - EGFL6 antibody royalty payment; SiRNA delivery (patents on DOPC, rHDL)
(OPTIONAL) Uncompensated Relationships - Elsevier
 
Anthony Paul Conley
Consulting or Advisory Role - Bayer; Deciphera; Deciphera; Genentech; Guidepoint Global; InhibRx; Medscape; Nektar; Novartis; OncLive; Schlesinger Associates
Research Funding - Bavarian Nordic (Inst); Ignyta (Inst); Iovance Biotherapeutics (Inst); MedImmune (Inst); NantHealth (Inst)
Travel, Accommodations, Expenses - Genentech
 
Gabriele E Urschel
No Relationships to Disclose
 
Diane I. Healey
Employment - BioXcel Therapeutics
Stock and Other Ownership Interests - BioXcel Therapeutics; Bristol-Myers Squibb; Pfizer
 
Vincent O'Neill
Employment - BioXcel Therapeutics
Leadership - BioXcel Therapeutics
Stock and Other Ownership Interests - BioXcel Therapeutics
 
Filip Janku
Stock and Other Ownership Interests - Trovagene
Consulting or Advisory Role - Deciphera; Foundation Medicine; Guardant Health; IDEAYA Biosciences; IFM Therapeutics; Immunomet; Jazz Pharmaceuticals; Novartis; PureTech; Sequenom; Sotio; Synlogic; Trovagene; Valeant/Dendreon
Research Funding - Agios (Inst); Asana Biosciences (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); Fujifilm (Inst); Genentech (Inst); Novartis (Inst); Piqur (Inst); Plexxikon (Inst); Proximagen (Inst); Roche (Inst); Symphogen (Inst)
Other Relationship - Bio-Rad